Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Non-Current Deffered Revenue (2019 - 2020)

Pliant Therapeutics has reported Non-Current Deffered Revenue over the past 2 years, most recently at $581000.0 for Q4 2020.

  • Quarterly Non-Current Deffered Revenue rose 26.86% to $581000.0 in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $581000.0 through Dec 2020, up 26.86% year-over-year, with the annual reading at $581000.0 for FY2020, 26.86% up from the prior year.
  • Non-Current Deffered Revenue was $581000.0 for Q4 2020 at Pliant Therapeutics, up from $565000.0 in the prior quarter.
  • Over five years, Non-Current Deffered Revenue peaked at $581000.0 in Q4 2020 and troughed at $458000.0 in Q4 2019.